• 1. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 2. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 3. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 4. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 5. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466

• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Alkyl halides Cyclohexyl halides

Comprehensive Overview of (1R,2R)-2-fluorocyclohexan-1-amine hydrochloride (CAS No. 1820580-16-2)

The compound (1R,2R)-2-fluorocyclohexan-1-amine hydrochloride (CAS No. 1820580-16-2) is a fluorinated cyclohexylamine derivative with significant potential in pharmaceutical and chemical research. Its unique stereochemistry and functional groups make it a valuable intermediate in the synthesis of bioactive molecules. Researchers are increasingly interested in this compound due to its role in chiral synthesis and drug discovery, particularly in the development of CNS-targeting therapeutics and enzyme inhibitors.

One of the key features of (1R,2R)-2-fluorocyclohexan-1-amine hydrochloride is its stereospecificity, which is critical for achieving high enantiomeric purity in pharmaceutical applications. The presence of the fluorine atom at the 2-position of the cyclohexane ring enhances the compound's metabolic stability and binding affinity, making it a preferred choice for medicinal chemistry projects. Recent studies have explored its utility in protease inhibition and GPCR modulation, aligning with the growing demand for precision-targeted therapies.

In the context of green chemistry, (1R,2R)-2-fluorocyclohexan-1-amine hydrochloride has garnered attention for its potential in sustainable synthesis. Researchers are investigating eco-friendly catalytic methods to produce this compound, reducing reliance on hazardous reagents. This aligns with the broader industry shift toward environmentally benign processes, a topic frequently searched by professionals in pharmaceutical manufacturing and academic research.

The compound's physicochemical properties, such as solubility and stability under physiological conditions, are also areas of active investigation. These properties are crucial for its application in formulation development and preclinical studies. For instance, its hydrochloride salt form improves bioavailability, a factor often queried in drug delivery optimization discussions. Additionally, its compatibility with high-throughput screening platforms makes it a candidate for lead compound identification in early-stage drug discovery.

From a commercial perspective, (1R,2R)-2-fluorocyclohexan-1-amine hydrochloride is listed in catalogs of specialty chemical suppliers, often under categories like building blocks or pharmaceutical intermediates. Its pricing and scalability are common queries among procurement specialists, reflecting the balance between cost-efficiency and quality in bulk chemical sourcing. Regulatory compliance, particularly regarding GMP standards, is another frequently searched topic, as industries prioritize adherence to global safety guidelines.

In summary, (1R,2R)-2-fluorocyclohexan-1-amine hydrochloride (CAS No. 1820580-16-2) represents a versatile and scientifically relevant compound with applications spanning drug development, catalysis, and material science. Its alignment with trends like chiral technology and sustainable chemistry ensures its continued relevance in both academic and industrial settings. Future research may further elucidate its potential in emerging fields such as bioconjugation and therapeutic peptide design.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)